Cargando…
Course of postoperative relapse in non‐small cell lung cancer is strongly associated with post‐progression survival
BACKGROUND: For early‐stage non‐small cell lung cancer (NSCLC), surgical resection is considered the most effective treatment strategy and curative treatment. Unfortunately, even after complete resection, almost half of all patients with stage I–IIIA NSCLC relapse and die. Although the possibility o...
Autores principales: | Imai, Hisao, Onozato, Ryoichi, Kaira, Kyoichi, Kawashima, Sayaka, Masubuchi, Ken, Nagashima, Toshiteru, Tajima, Kohei, Minato, Koichi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons Australia, Ltd
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8520813/ https://www.ncbi.nlm.nih.gov/pubmed/34477313 http://dx.doi.org/10.1111/1759-7714.14119 |
Ejemplares similares
-
Post-Progression Survival Is Strongly Associated with Overall Survival in Patients Exhibiting Postoperative Relapse of Non-Small-Cell Lung Cancer Harboring Sensitizing EGFR Mutations
por: Imai, Hisao, et al.
Publicado: (2021) -
Management of Lung Cancer-Associated Malignant Pericardial Effusion with Intrapericardial Administration of Carboplatin: A Retrospective Study
por: Imai, Hisao, et al.
Publicado: (2021) -
Clinical Impact of Post-progression Survival in Patients with Locally Advanced Non-small Cell Lung Cancer After Chemoradiotherapy
por: Imai, Hisao, et al.
Publicado: (2022) -
Clinical significance of post‐progression survival in lung cancer
por: Imai, Hisao, et al.
Publicado: (2017) -
Post‐progression survival is highly linked to overall survival in patients with non‐small‐cell lung cancer harboring sensitive EGFR mutations treated with first‐line epidermal growth factor receptor‐tyrosine kinase inhibitors
por: Imai, Hisao, et al.
Publicado: (2019)